Development of an Injectable Slow-Release Metformin Formulation and Evaluation of Its Potential Antitumor Effects

Metformin is an antidiabetic drug which possesses antiproliferative activity in cancer cells when administered at high doses, due to its unfavorable pharmacokinetics. The aim of this work was to develop a pharmacological tool for the release of metformin in proximity of the tumor, allowing high loca...

Descripción completa

Detalles Bibliográficos
Autores principales: Baldassari, Sara, Solari, Agnese, Zuccari, Guendalina, Drava, Giuliana, Pastorino, Sara, Fucile, Carmen, Marini, Valeria, Daga, Antonio, Pattarozzi, Alessandra, Ratto, Alessandra, Ferrari, Angelo, Mattioli, Francesca, Barbieri, Federica, Caviglioli, Gabriele, Florio, Tullio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834504/
https://www.ncbi.nlm.nih.gov/pubmed/29500390
http://dx.doi.org/10.1038/s41598-018-22054-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834504/
https://www.ncbi.nlm.nih.gov/pubmed/29500390
http://dx.doi.org/10.1038/s41598-018-22054-w

Ejemplares similares